API
< Back to all clusters
[BUSINESS] · Australia · 3 sources

started · updated

ResMed reports Q3 revenue of $1.41 billion, beating analyst estimates

Medical device company ResMed announced revenue of $1.41 billion for calendar Q3 2026, representing a 5.9% increase year-on-year. This figure exceeded S&P analysts’ consensus estimates of $1.39 billion.

The company reported a non-GAAP adjusted earnings per share of $2.91, which was 8.9% above the consensus estimate of $2.67. CEO Mick Farrell attributed the performance to global demand for sleep and breathing health solutions and the proceeds from the divestiture of MatrixCare.

While revenue and earnings grew, the operating margin decreased to 32% from 33.4% in the same quarter last year. The free cash flow margin also saw a decline, falling to 26.4% from 31% in the previous year.

Entities

MatrixCare · Mick Farrell · ResMed